AstraZeneca Likely To Reduce Its Contract Sales Force, PDI Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The sales and marketing staffing firm currently contracts 800 reps to AstraZeneca.
You may also be interested in...
Sanofi-Aventis Ends PDI Sales Contract
Big pharma is “reevaluating its commercial model,” PDI said in reaction to losing the $18 mil. to $20 mil. Sanofi contract.
Sanofi-Aventis Ends PDI Sales Contract
Big pharma is “reevaluating its commercial model,” PDI said in reaction to losing the $18 mil. to $20 mil. Sanofi contract.
PDI Reducing Reliance On Top Pharma Clients
Contract sales organization’s top four clients – AstraZeneca, GSK, Novartis and Sanofi-Aventis – will represent 59% of 2005 revenue, versus 81% in 2004, PDI says. Contracts with three of the four companies have been renewed.